Group One Trading
PETX

Group One Trading’s Aratana Therapeutics, Inc. PETX Stock Holding History

Group One Trading’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,900
Closed -$10K – 5880
2019
Q2 		$10K Sell
1,900
-1,941
-51% -$8.72K ﹤0.01% 4435
2019
Q1 		$14K Buy
3,841
+376
+11% +$1.63K ﹤0.01% 4175
2018
Q4 		$21K Sell
3,465
-1,216
-26% -$7.42K ﹤0.01% 4012
2018
Q3 		$27K Buy
4,681
+1,000
+27% +$5K ﹤0.01% 4290
2018
Q2 		$16K Sell
3,681
-6,190
-63% -$31.2K ﹤0.01% 4476
2018
Q1 		$44K Buy
9,871
+3,652
+59% +$16.3K ﹤0.01% 3731
2017
Q4 		$33K Buy
6,219
+1,012
+19% +$6.19K ﹤0.01% 3945
2017
Q3 		$32K Sell
5,207
-13,010
-71% -$82.3K ﹤0.01% 3852
2017
Q2 		$132K Sell
18,217
-56,269
-76% -$346K ﹤0.01% 2941
2017
Q1 		$395K Buy
+74,486
New +$503K ﹤0.01% 2016
2016
Q4 		– Sell
-570
Closed -$4.61K – 5067
2016
Q3 		$5K Buy
+570
New +$4.73K ﹤0.01% 4236
2016
Q2 		– Sell
-700
Closed -$4.5K – 5128
2016
Q1 		$4K Buy
+700
New +$2.63K ﹤0.01% 4272
2015
Q4 		– Sell
-500
Closed -$3.3K – 5336
2015
Q3 		$4K Sell
500
-5,800
-92% -$98.2K ﹤0.01% 4583
2015
Q2 		$95K Sell
6,300
-1,300
-17% -$18.8K ﹤0.01% 3129
2015
Q1 		$122K Buy
+7,600
New +$135K ﹤0.01% 2759
2014
Q3 		– Sell
-2,336
Closed -$28.3K – 5629
2014
Q2 		$36K Buy
+2,336
New +$33.1K ﹤0.01% 3766

Other funds holding PETX

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Group One Trading's PETX Position: Q3 2019 in Review

Group One Trading sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 1,900 shares — an estimated $10K sold.

Group One Trading first reported a position in PETX in Q2 2014 and held it in 16 quarters. The position peaked at $395K in Q1 2017. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Group One Trading reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Group One Trading sold 1,900 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $10K.
  • Group One Trading first reported a position in Aratana Therapeutics, Inc. in Q2 2014 and held it in 16 quarters.
  • Group One Trading's Aratana Therapeutics, Inc. position peaked at $395K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Group One Trading's 13F filing for Q3 2019, filed 12 Nov 2019.